Thermo Fisher Scientific / Olink merger inquiry
The CMA has investigated and cleared the anticipated acquisition by Thermo Fisher Scientific Inc. of Olink Holding AB.
Statutory timetable
| Phase 1 | Action |
| 30 July 2024 | Decision published |
| 8 July 2024 | Decision announced |
| 10 May 2024 | Launch of merger inquiry |
| 2 February 2024 to 23 February 2024 | Invitation to comment |
Phase 1
CMA clearance decision
8 July 2024: The CMA has cleared the anticipated acquisition by Thermo Fisher Scientific Inc. of Olink Holding AB.
- (30.7.24)
Launch of merger inquiry
10 May 2024: The CMA announced the launch of its merger inquiry by notice to the parties.
- (10.5.24)
Invitation to comment: closed
2 February 2024: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
To assist it with this assessment, the CMA invites comments on the merger from any interested party.
These comments should be provided by the deadline set out above.
Contact
Please send written representations about any competition or public interest to [email protected].
Updates to this page
Published 2 February 2024Last updated 30 July 2024 + show all updates
-
Full text decision published
-
Clearance decision announced.
-
Commencement notice published.
-
First published.